Abcellera Biologicsinc Stock Performance

ABCL Stock  USD 3.91  0.01  0.26%   
The firm shows a Beta (market volatility) of 2.18, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Abcellera BiologicsInc will likely underperform. Abcellera BiologicsInc has an expected return of -0.49%. Please make sure to confirm Abcellera BiologicsInc maximum drawdown, rate of daily change, and the relationship between the jensen alpha and kurtosis , to decide if Abcellera BiologicsInc performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abcellera BiologicsInc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in May 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more

Actual Historical Performance (%)

One Day Return
(0.26)
Five Day Return
(10.11)
Year To Date Return
(31.76)
Ten Year Return
(93.36)
All Time Return
(93.36)
1
AbCellera Biologics Inc Faces Net Loss in FY 2023 Amid Strategic Shifts
02/20/2024
2
After losing 38 percent in the past year, AbCellera Biologics Inc. institutional owners must be relieved by the recent gain
02/29/2024
3
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
03/05/2024
4
AbCellera gains on antibody collaboration with Biogen
03/11/2024
5
AbCellera Biologics Inc. Receives Consensus Rating of Buy from Analysts - MarketBeat
03/12/2024
6
Graham Capital Management L.P. Increases Stock Position in AbCellera Biologics Inc. - Defense World
03/15/2024
7
Acquisition by Carl Hansen of 920312 shares of Abcellera BiologicsInc at 14.55 subject to Rule 16b-3
03/22/2024
8
American Century Companies Inc. Has 4. Million Stake in AbCellera Biologics Inc. - Defense World
03/28/2024
9
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
04/08/2024
10
AbCellera Biologics Hits New 12-Month Low at 3.84 - MarketBeat
04/18/2024
Begin Period Cash Flow414.6 M
  

Abcellera BiologicsInc Relative Risk vs. Return Landscape

If you would invest  551.00  in Abcellera BiologicsInc on January 20, 2024 and sell it today you would lose (160.00) from holding Abcellera BiologicsInc or give up 29.04% of portfolio value over 90 days. Abcellera BiologicsInc is currently does not generate positive expected returns and assumes 3.1499% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Abcellera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Abcellera BiologicsInc is expected to under-perform the market. In addition to that, the company is 5.07 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.1 per unit of volatility.

Abcellera BiologicsInc Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abcellera BiologicsInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abcellera BiologicsInc, and traders can use it to determine the average amount a Abcellera BiologicsInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1567

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsABCL

Estimated Market Risk

 3.15
  actual daily
27
73% of assets are more volatile

Expected Return

 -0.49
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.16
  actual daily
0
Most of other assets perform better
Based on monthly moving average Abcellera BiologicsInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abcellera BiologicsInc by adding Abcellera BiologicsInc to a well-diversified portfolio.

Abcellera BiologicsInc Fundamentals Growth

Abcellera Stock prices reflect investors' perceptions of the future prospects and financial health of Abcellera BiologicsInc, and Abcellera BiologicsInc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abcellera Stock performance.

About Abcellera BiologicsInc Performance

To evaluate Abcellera BiologicsInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abcellera BiologicsInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abcellera Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abcellera BiologicsInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Abcellera's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 13.08  9.55 
Return On Tangible Assets(0.11)(0.11)
Return On Capital Employed(0.17)(0.16)
Return On Assets(0.1)(0.09)
Return On Equity(0.13)(0.12)

Things to note about Abcellera BiologicsInc performance evaluation

Checking the ongoing alerts about Abcellera BiologicsInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abcellera BiologicsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Abcellera BiologicsInc generated a negative expected return over the last 90 days
Abcellera BiologicsInc has high historical volatility and very poor performance
The company reported the previous year's revenue of 38.02 M. Net Loss for the year was (146.4 M) with profit before overhead, payroll, taxes, and interest of 311.11 M.
Abcellera BiologicsInc currently holds about 868.21 M in cash with (43.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04.
Roughly 28.0% of the company shares are held by company insiders
Latest headline from news.google.com: AbCellera Biologics Hits New 12-Month Low at 3.84 - MarketBeat
Evaluating Abcellera BiologicsInc's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Abcellera BiologicsInc's stock performance include:
  • Analyzing Abcellera BiologicsInc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abcellera BiologicsInc's stock is overvalued or undervalued compared to its peers.
  • Examining Abcellera BiologicsInc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Abcellera BiologicsInc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abcellera BiologicsInc's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Abcellera BiologicsInc's stock. These opinions can provide insight into Abcellera BiologicsInc's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Abcellera BiologicsInc's stock performance is not an exact science, and many factors can impact Abcellera BiologicsInc's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Abcellera BiologicsInc is a strong investment it is important to analyze Abcellera BiologicsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera BiologicsInc's future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Abcellera Stock analysis

When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.459
Earnings Share
(0.51)
Revenue Per Share
0.131
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.1)
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.